Spanish English

On March 14 of this year, Pediatric Neurologist Saúl Garza presented to the country and the world the first study of cannabidiol in patients with Lennox-Gastaut syndrome. The data is quite impressive when RSHO-X was used compared to another similar study from 2015 where Epidiolex, a pharmaceutical-grade cannabis drug, was used.